Movement Alert|Oracle Falls 3.02% in Regular Trading, Intraday Reversal Erases Pentagon Contract Gains as Credit and Cost Pressures Persist

Market Focus
Jul 24

On July 24, Oracle fell 3.02% in regular trading to $116.40/share, with turnover of $1.23 billion. The stock initially rose over 2% at the open following news of a major Pentagon contract but sharply reversed during the session.

On the news front, Oracle secured a 10-year enterprise software agreement with the US Department of Defense valued at up to $7 billion, with a base five-year value of $3.31 billion. However, the positive catalyst was overwhelmed by persistent headwinds. Reports emerged that Oracle is exploring a sale of its stake in Oracle Financial Services in India, interpreted as a potential move to ease funding pressures. Additionally, Oracle's five-year CDS recently surged to approximately 203 basis points — an 18-year high — while S&P downgraded its rating to BBB-, just one notch above junk. The company also faces over $7 billion in collateral requirements for its Wisconsin data center project and billions in cost overruns at its New Mexico facility. These cumulative financial and credit concerns continue to overshadow near-term contract wins.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10